Circulating lethal toxin decreases the ability of neutrophils to respond to Bacillus anthracis

Cellular Microbiology

Volumn 16, Issue 4, 2014, Pages 504-518

  Weiner, Zachary P ^a   Ernst, Stephen M ^a   Boyer, Anne E ^b   Gallegos Candela, Maribel ^b   Barr, John R ^b   Glomski, Ian J ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; VIRULENCE FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHRAX; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INTOXICATION; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

ANIMAL STRUCTURES; ANIMALS; ANTHRAX; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HUMANS; MICE; NEUTROPHILS; SERUM;

EID: 84896405457     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/cmi.12232     Document Type: Article

References (56)

1. Agrawal, A., Lingappa, J., Leppla, S.H., Agrawal, S., Jabbar, A., Quinn, C., and Pulendran, B. (2003) Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin. Nature 424: 329-334.
2. Barth, H., Aktories, K., Popoff, M.R., and Stiles, B.G. (2004) Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins. Microbiol Mol Biol Rev 68: 373-402, table of contents.
3. Borregaard, N., and Cowland, J.B. (1997) Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89: 3503-3521.
4. Boyer, A.E., Quinn, C.P., Woolfitt, A.R., Pirkle, J.L., McWilliams, L.G., Stamey, K.L., etal. (2007) Detection and quantification of anthrax lethal factor in serum by mass spectrometry. Anal Chem 79: 8463-8470.
5. Brachman, P.S. (1980) Inhalation anthrax. Ann N Y Acad Sci 353: 83-93.
6. Brookmeyer, R., and Blades, N. (2002) Prevention of inhalational anthrax in the U.S. outbreak. Science 295: 1861.
7. Cote, C.K., Rea, K.M., Norris, S.L., van Rooijen, N., and Welkos, S.L. (2004) The use of a model of in vivo macrophage depletion to study the role of macrophages during infection with Bacillus anthracis spores. Microb Pathog 37: 169-175.
8. Cote, C.K., Van Rooijen, N., and Welkos, S.L. (2006) Roles of macrophages and neutrophils in the early host response to Bacillus anthracis spores in a mouse model of infection. Infect Immun 74: 469-480.
9. Crawford, M.A., Aylott, C.V., Bourdeau, R.W., and Bokoch, G.M. (2006) Bacillus anthracis toxins inhibit human neutrophil NADPH oxidase activity. J Immunol 176: 7557-7565.
10. Duesbery, N.S., Webb, C.P., Leppla, S.H., Gordon, V.M., Klimpel, K.R., Copeland, T.D., etal. (1998) Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 280: 734-737.
11. During, R.L., Li, W., Hao, B., Koenig, J.M., Stephens, D.S., Quinn, C.P., and Southwick, F.S. (2005) Anthrax lethal toxin paralyzes neutrophil actin-based motility. J Infect Dis 192: 837-845.
12. Eisenhauer, P.B., and Lehrer, R.I. (1992) Mouse neutrophils lack defensins. Infect Immun 60: 3446-3447.
13. Glomski, I.J., Fritz, J.H., Keppler, S.J., Balloy, V., Chignard, M., Mock, M., and Goossens, P.L. (2007a) Murine splenocytes produce inflammatory cytokines in a MyD88-dependent response to Bacillus anthracis spores. Cell Microbiol 9: 502-513.
14. Glomski, I.J., Piris-Gimenez, A., Huerre, M., Mock, M., and Goossens, P.L. (2007b) Primary involvement of pharynx and Peyer's patch in inhalational and intestinal anthrax. PLoS Pathog 3: e76.
15. Goossens, P.L. (2009) Animal models of human anthrax: the Quest for the Holy Grail. Mol Aspects Med 30: 467-480.
16. Ivanova, N., Sorokin, A., Anderson, I., Galleron, N., Candelon, B., Kapatral, V., etal. (2003) Genome sequence of Bacillus cereus and comparative analysis with Bacillus anthracis. Nature 423: 87-91.
17. Janes, B.K., and Stibitz, S. (2006) Routine markerless gene replacement in Bacillus anthracis. Infect Immun 74: 1949-1953.
18. Kintzer, A.F., Thoren, K.L., Sterling, H.J., Dong, K.C., Feld, G.K., Tang, I.I., etal. (2009) The protective antigen component of anthrax toxin forms functional octameric complexes. J Mol Biol 392: 614-629.
19. Kintzer, A.F., Tang, I.I., Schawel, A.K., Brown, M.J., and Krantz, B.A. (2012) Anthrax toxin protective antigen integrates poly-gamma-D-glutamate and pH signals to sense the optimal environment for channel formation. Proc Natl Acad Sci USA 109: 18378-18383.
20. Leppla, S.H. (1982) Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc Natl Acad Sci USA 79: 3162-3166.
21. Levchenko, A., and Iglesias, P.A. (2002) Models of eukaryotic gradient sensing: application to chemotaxis of amoebae and neutrophils. Biophys J 82: 50-63.
22. Lin, F., Nguyen, C.M., Wang, S.J., Saadi, W., Gross, S.P., and Jeon, N.L. (2004) Effective neutrophil chemotaxis is strongly influenced by mean IL-8 concentration. Biochem Biophys Res Commun 319: 576-581.
23. Liu, S., Wang, H., Currie, B.M., Molinolo, A., Leung, H.J., Moayeri, M., etal. (2008) Matrix metalloproteinase-activated anthrax lethal toxin demonstrates high potency in targeting tumor vasculature. J Biol Chem 283: 529-540.
24. Liu, S., Miller-Randolph, S., Crown, D., Moayeri, M., Sastalla, I., Okugawa, S., and Leppla, S.H. (2010) Anthrax toxin targeting of myeloid cells through the CMG2 receptor is essential for establishment of Bacillus anthracis infections in mice. Cell Host Microbe 8: 455-462.
25. Lovchik, J.A., Drysdale, M., Koehler, T.M., Hutt, J.A., and Lyons, C.R. (2012) Expression of either lethal toxin or edema toxin by Bacillus anthracis is sufficient for virulence in a rabbit model of inhalational anthrax. Infect Immun 80: 2414-2425.
26. Loving, C.L., Khurana, T., Osorio, M., Lee, G.M., Kelly, V.K., Stibitz, S., and Merkel, T.J. (2009) Role of anthrax toxins in dissemination, disease progression, and induction of protective adaptive immunity in the mouse aerosol challenge model. Infect Immun 77: 255-265.
27. Lowe, D.E., and Glomski, I.J. (2012) Cellular and physiological effects of anthrax exotoxin and its relevance to disease. Front Cell Infect Microbiol 2: 76.
28. Makino, S., Uchida, I., Terakado, N., Sasakawa, C., and Yoshikawa, M. (1989) Molecular characterization and protein analysis of the cap region, which is essential for encapsulation in Bacillus anthracis. J Bacteriol 171: 722-730.
29. Makino, S., Watarai, M., Cheun, H.I., Shirahata, T., and Uchida, I. (2002) Effect of the lower molecular capsule released from the cell surface of Bacillus anthracis on the pathogenesis of anthrax. J Infect Dis 186: 227-233.
30. Mauer, A.M., Athens, J.W., Ashenbrucker, H., Cartwright, G.E., and Wintrobe, M.M. (1960) Leukokinetic studies. Ii. A method for labeling granulocytes in vitro with radioactive Diisopropylfluorophosphate (Dfp). J Clin Invest 39: 1481-1486.
31. Mayer-Scholl, A., Hurwitz, R., Brinkmann, V., Schmid, M., Jungblut, P., Weinrauch, Y., and Zychlinsky, A. (2005) Human neutrophils kill Bacillus anthracis. PLoS Pathog 1: e23.
32. Meselson, M., Guillemin, J., Hugh-Jones, M., Langmuir, A., Popova, I., Shelokov, A., and Yampolskaya, O. (1994) The Sverdlovsk anthrax outbreak of 1979. Science 266: 1202-1208.
33. Moayeri, M., and Leppla, S.H. (2009) Cellular and systemic effects of anthrax lethal toxin and edema toxin. Mol Aspects Med 30: 439-455.
34. Moayeri, M., Haines, D., Young, H.A., and Leppla, S.H. (2003) Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice. J Clin Invest 112: 670-682.
35. Moayeri, M., Wiggins, J.F., and Leppla, S.H. (2007) Anthrax protective antigen cleavage and clearance from the blood of mice and rats. Infect Immun 75: 5175-5184.
36. Moayeri, M., Crown, D., Newman, Z.L., Okugawa, S., Eckhaus, M., Cataisson, C., etal. (2010) Inflammasome sensor Nlrp1b-dependent resistance to anthrax is mediated by caspase-1, IL-1 signaling and neutrophil recruitment. PLoS Pathog 6: e1001222.
37. Mock, M., and Fouet, A. (2001) Anthrax. Annu Rev Microbiol 55: 647-671.
38. Mukherjee, D.V., Tonry, J.H., Kim, K.S., Ramarao, N., Popova, T.G., Bailey, C., etal. (2011) Bacillus anthracis protease InhA increases blood-brain barrier permeability and contributes to cerebral hemorrhages. PLoS ONE 6: e17921.
39. O'Brien, J., Friedlander, A., Dreier, T., Ezzell, J., and Leppla, S. (1985) Effects of anthrax toxin components on human neutrophils. Infect Immun 47: 306-310.
40. Otto, M. (2012) MRSA virulence and spread. Cell Microbiol 14: 1513-1521. doi: 10.1111/j.1462-5822.2012.01832.x. Epub 17 July 2012. PMID: 22747834.
41. Paccani, S.R., and Baldari, C.T. (2011) T cell targeting by anthrax toxins: two faces of the same coin. Toxins (Basel) 3: 660-671.
42. Preshaw, P.M., Schifferle, R.E., and Walters, J.D. (1999) Porphyromonas gingivalis lipopolysaccharide delays human polymorphonuclear leukocyte apoptosis in vitro. J Periodontal Res 34: 197-202.
43. Rossi Paccani, S., Tonello, F., Patrussi, L., Capitani, N., Simonato, M., Montecucco, C., and Baldari, C.T. (2007) Anthrax toxins inhibit immune cell chemotaxis by perturbing chemokine receptor signalling. Cell Microbiol 9: 924-929.
44. Safran, M., Kim, W.Y., Kung, A.L., Horner, J.W., DePinho, R.A., and Kaelin, W.G., Jr (2003) Mouse reporter strain for noninvasive bioluminescent imaging of cells that have undergone Cre-mediated recombination. Mol Imaging 2: 297-302.
45. Schneerson, R., Kubler-Kielb, J., Liu, T.Y., Dai, Z.D., Leppla, S.H., Yergey, A., etal. (2003) Poly(gamma-D-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: a potential addition to the anthrax vaccine. Proc Natl Acad Sci USA 100: 8945-8950.
46. Stanley, J.L., and Smith, H. (1961) Purification of factor I and recognition of a third factor of anthrax toxin. J Gen Microbiol 282: 49-66.
47. Stevens, D.L., Aldape, M.J., and Bryant, A.E. (2012) Life-threatening clostridial infections. Anaerobe 18: 254-259. doi: 10.1016/j.anaerobe.2011.11.001. Epub 20 November 2011. PMID: 22120198.
48. Summers, C., Rankin, S.M., Condliffe, A.M., Singh, N., Peters, A.M., and Chilvers, E.R. (2010) Neutrophil kinetics in health and disease. Trends Immunol 31: 318-324.
49. Szarowicz, S.E., During, R.L., Li, W., Quinn, C.P., Tang, W.J., and Southwick, F.S. (2009) Bacillus anthracis edema toxin impairs neutrophil actin-based motility. Infect Immun 77: 2455-2464.
50. Tkalcevic, J., Novelli, M., Phylactides, M., Iredale, J.P., Segal, A.W., and Roes, J. (2000) Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity 12: 201-210.
51. Vitale, G., Pellizzari, R., Recchi, C., Napolitani, G., Mock, M., and Montecucco, C. (1998) Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. Biochem Biophys Res Commun 248: 706-711.
52. Wade, B.H., Wright, G.G., Hewlett, E.L., Leppla, S.H., and Mandell, G.L. (1985) Anthrax toxin components stimulate chemotaxis of human polymorphonuclear neutrophils. Proc Soc Exp Biol Med 179: 159-162.
53. Walsh, J.J., Pesik, N., Quinn, C.P., Urdaneta, V., Dykewicz, C.A., Boyer, A.E., etal. (2007) A case of naturally acquired inhalation anthrax: clinical care and analyses of anti-protective antigen immunoglobulin G and lethal factor. Clin Infect Dis 44: 968-971.
54. Weiner, Z.P., Boyer, A.E., Gallegos-Candela, M., Cardani, A.N., Barr, J.R., and Glomski, I.J. (2012) Debridement increases survival in a mouse model of subcutaneous anthrax. PLoS ONE 7: e30201.
55. Welkos, S.L., Trotter, R.W., Becker, D.M., and Nelson, G.O. (1989) Resistance to the Sterne strain of B. anthracis: phagocytic cell responses of resistant and susceptible mice. Microb Pathog 7: 15-35.
56. Xu, L., Fang, H., and Frucht, D.M. (2008) Anthrax lethal toxin increases superoxide production in murine neutrophils via differential effects on MAPK signaling pathways. J Immunol 180: 4139-4147.